252 related articles for article (PubMed ID: 21784901)
21. C3 glomerulopathy: what's in a name?
D'Agati VD; Bomback AS
Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
[TBL] [Abstract][Full Text] [Related]
22. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
Viswanathan GK; Nada R; Kumar A; Ramachandran R; Rayat CS; Jha V; Sakhuja V; Joshi K
Diagn Pathol; 2015 Mar; 10():6. PubMed ID: 25889427
[TBL] [Abstract][Full Text] [Related]
23. Genetic analysis of the complement pathway in C3 glomerulopathy.
Zhao W; Ding Y; Lu J; Zhang T; Chen D; Zhang H; Zeng C; Liu Z; Chen H
Nephrol Dial Transplant; 2018 Nov; 33(11):1919-1927. PubMed ID: 29566171
[TBL] [Abstract][Full Text] [Related]
24. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
[TBL] [Abstract][Full Text] [Related]
25. Retinal disease in the C3 glomerulopathies and the risk of impaired vision.
Savige J; Amos L; Ierino F; Mack HG; Symons RC; Hughes P; Nicholls K; Colville D
Ophthalmic Genet; 2016 Dec; 37(4):369-376. PubMed ID: 26915021
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease.
Tran CL; Sethi S; Murray D; Cramer CH; Sas DJ; Willrich M; Smith RJ; Fervenza FC
Pediatr Nephrol; 2016 Apr; 31(4):683-7. PubMed ID: 26759144
[TBL] [Abstract][Full Text] [Related]
27. [Changes in the complement system in membranoproliferative glomerulonephritis].
Yurova VA; Bobrova LA; Kozlovskaya NL; Korotchaeva YV; Serova AG; Kozlov LV; Andina SS; Demyanova KA; Kuchieva AM; Roshchupkina SV
Ter Arkh; 2017; 89(6):69-77. PubMed ID: 28745692
[TBL] [Abstract][Full Text] [Related]
28. Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway.
Sethi S; Gamez JD; Vrana JA; Theis JD; Bergen HR; Zipfel PF; Dogan A; Smith RJ
Kidney Int; 2009 May; 75(9):952-60. PubMed ID: 19177158
[TBL] [Abstract][Full Text] [Related]
29. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs.
de Cordoba SR; Tortajada A; Harris CL; Morgan BP
Immunobiology; 2012 Nov; 217(11):1034-46. PubMed ID: 22964229
[TBL] [Abstract][Full Text] [Related]
30. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
[TBL] [Abstract][Full Text] [Related]
31. von Willebrand factor variants in C3 glomerulopathy: A Chinese cohort study.
Chen YY; Han SS; Cao Y; Yu XJ; Zhu L; Luo JC; Song WC; Yu F; Mao YH; Zhao MH
Clin Immunol; 2021 Aug; 229():108794. PubMed ID: 34245915
[TBL] [Abstract][Full Text] [Related]
32. Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.
Donadelli R; Pulieri P; Piras R; Iatropoulos P; Valoti E; Benigni A; Remuzzi G; Noris M
Front Immunol; 2018; 9():2329. PubMed ID: 30487789
[TBL] [Abstract][Full Text] [Related]
33. Characterization of C3 in C3 glomerulopathy.
Sethi S; Vrana JA; Fervenza FC; Theis JD; Sethi A; Kurtin PJ; Zhang Y; Smith RJH
Nephrol Dial Transplant; 2017 Mar; 32(3):459-465. PubMed ID: 27507892
[TBL] [Abstract][Full Text] [Related]
34. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
Ding Y; Zhao W; Zhang T; Qiang H; Lu J; Su X; Wen S; Xu F; Zhang M; Zhang H; Zeng C; Liu Z; Chen H
Sci Rep; 2017 Jul; 7(1):6004. PubMed ID: 28729648
[TBL] [Abstract][Full Text] [Related]
35. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.
Lesher AM; Zhou L; Kimura Y; Sato S; Gullipalli D; Herbert AP; Barlow PN; Eberhardt HU; Skerka C; Zipfel PF; Hamano T; Miwa T; Tung KS; Song WC
J Am Soc Nephrol; 2013 Jan; 24(1):53-65. PubMed ID: 23204401
[TBL] [Abstract][Full Text] [Related]
36. C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.
Zhang Y; Meyer NC; Fervenza FC; Lau W; Keenan A; Cara-Fuentes G; Shao D; Akber A; Fremeaux-Bacchi V; Sethi S; Nester CM; Smith RJH
Am J Kidney Dis; 2017 Dec; 70(6):834-843. PubMed ID: 28838767
[TBL] [Abstract][Full Text] [Related]
37. Dense deposit disease associated with monoclonal gammopathy of undetermined significance.
Sethi S; Sukov WR; Zhang Y; Fervenza FC; Lager DJ; Miller DV; Cornell LD; Krishnan SG; Smith RJ
Am J Kidney Dis; 2010 Nov; 56(5):977-82. PubMed ID: 20832153
[TBL] [Abstract][Full Text] [Related]
38. Complement genetics and host defence.
Lachmann PJ
Zentralbl Bakteriol; 1990 Dec; 274(3):316-24. PubMed ID: 2151023
[TBL] [Abstract][Full Text] [Related]
39. Dense deposit disease.
Smith RJ; Harris CL; Pickering MC
Mol Immunol; 2011 Aug; 48(14):1604-10. PubMed ID: 21601923
[TBL] [Abstract][Full Text] [Related]
40. C3 alleles in diseases associated with C3 activation.
Welch TR; Berry A
Dis Markers; 1987 Jun; 5(2):81-7. PubMed ID: 3502986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
